查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1750810

醫藥契約製造和實驗室服務市場規模、佔有率、趨勢分析報告：按服務、地區和細分市場預測，2025 年至 2030 年

Pharmaceutical Contract Manufacturing And Research Services Market Size, Share & Trends Analysis Report By Service (Manufacturing, Research), By Region (North America, Europe, Asia Pacific, Latin America), And Segment Forecasts, 2025 - 2030
出版日期: | 出版商: Grand View Research | 英文 100 Pages | 商品交期: 2-10個工作天內

價格

製藥契約製造和研究服務市場的成長和趨勢：

根據Grand View Research, Inc.的最新報告，全球醫藥契約製造和實驗室服務市場規模預計到2030年將達到3,952.3億美元，2025年至2030年期間的複合年成長率為6.9%。

製藥公司擴大轉向CMO和CDMO，以避免在基礎設施方面進行大規模資本投資，並應對複雜的監管環境。這項策略措施使他們能夠將資源集中在核心競爭力上，例如藥物研發和商業化。專業合約組織實現的規模經濟也有助於降低生產成本。

藥物開發日益複雜，尤其生技藥品、生物相似藥、高效能原料藥和個人化藥物而言，這需要合約服務提供者俱備先進的能力和專業知識。這些機構通常持有最尖端科技，例如連續生產和先進的處理系統，這些技術對於高效合規的生產至關重要。

全球健康趨勢，例如慢性病盛行率上升，以及由於專利到期而對價格合理的學名藥和生物類似藥的需求，也是主要的成長動力。日益嚴格且不斷變化的法規環境，加上快速進入市場的需求，促使製藥公司利用CMO和CDMO的成熟專業知識。向亞太地區等成本競爭力強的地區進行策略性地理轉移，以及提供全面解決方案的CRO-CDMO一體化模式的出現，支撐了該市場的蓬勃發展。

醫藥契約製造和研究服務市場報告重點

  • 生產學名藥、生物相似藥和疫苗的規模和成本效益的需求正在推動市場的發展。
  • 契約製造提供必要的產能、靈活性和監管支持，以推動亞太地區的發展。
  • 預計在預測期內，醫藥契約製造的複合年成長率最快，為 7.0%。
  • 複雜領域的研發不斷增加以及對 CRO 專業知識的需求使得透過先進技術和遵循複雜法規可以節省全球臨床臨床實驗的成本和時間。
  • 亞太地區醫藥契約製造和實驗室服務市場佔據全球市場主導地位，2024 年的收入佔有率超過 40.0%。這是由於製造能力的擴大和對 CMO 的投資增加，以及新加坡、中國和印度等新興經濟體外包業務的增加。
  • 2024年11月，瑞士龍沙公司宣布大幅擴建其位於菲斯普的生物偶聯產能。該投資將包括新增兩套1,200公升的生產設施，以滿足不斷成長的市場需求。

目錄

第1章調查方法與範圍

第2章執行摘要

第3章製藥契約製造和實驗室服務市場變數、趨勢和範圍

  • 市場展望
    • 母市場展望
    • 相關/附隨市場展望
  • 市場動態
    • 市場促進因素分析
    • 市場限制因素分析
  • 醫藥契約製造與研究服務市場分析工具
    • 產業分析-波特五力分析
    • PESTEL分析

第4章：醫藥契約製造和研究服務市場：按服務估算和趨勢分析

  • 服務細分細分儀表板
  • 醫藥契約製造與研究服務市場：服務波動分析
  • 全球醫藥契約製造和研究服務市場規模和趨勢分析（按服務，2018-2030 年）
  • 製造業
    • 原料藥/原料藥
    • 先進的藥物傳輸配方
    • 包裹
    • 最終劑量配方
  • 研究
    • 腫瘤學
    • 疫苗
    • 發炎和免疫學
    • 心臟病學
    • 神經科學
    • 其他

第5章：醫藥契約製造與研究服務市場：區域估計與趨勢分析

  • 區域市場儀表板
  • 2024 年及 2030 年區域市場佔有率分析
  • 醫藥契約製造和實驗室服務市場（按地區）：關鍵要點
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 丹麥
    • 瑞典
    • 挪威
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 澳洲
    • 韓國
    • 泰國
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中東和非洲
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 科威特

第6章 競爭態勢

  • 主要市場參與企業的近期趨勢和影響分析
  • 公司/競爭對手分類
  • 供應商格局
    • Key company heat map analysis, 2024
  • 公司簡介
    • Catalent, Inc（Novo Holdings A/S）
    • PPD（Thermo Fisher Scientific Inc.）
    • AbbVie Inc.
    • Advent International, LP
    • Grifols
    • Dalton Pharma Services
    • Boehringer Ingelheim International GmbH
    • Lonza
Product Code: GVR-1-68038-924-1

Pharmaceutical Contract Manufacturing And Research Services Market Growth & Trends:

The global pharmaceutical contract manufacturing and research services market size is anticipated to reach USD 395.23 billion by 2030 and is projected to grow at a CAGR of 6.9% from 2025 to 2030, according to a new report by Grand View Research, Inc. Pharmaceutical companies are increasingly leveraging CMOs and CDMOs to avoid substantial capital investments in infrastructure and navigate complex regulatory landscapes. This strategic move allows them to concentrate resources on core competencies like drug discovery and commercialization. The economies of scale achieved by specialized contract organizations further contribute to reduced production costs.

The escalating complexity of drug development, particularly in biologics, biosimilars, HPAPIs, and personalized medicine, necessitates the advanced capabilities and expertise readily available within contract service providers. These organizations often possess cutting-edge technologies such as continuous manufacturing and sophisticated handling systems, which prove vital for efficient and compliant production.

Global health trends, including the rising prevalence of chronic diseases and the demand for affordable generics and biosimilars following patent expirations, are also key growth drivers. The stringent and evolving regulatory environment, coupled with the imperative for faster market entry, incentivizes pharmaceutical companies to utilize the established expertise of CMOs and CDMOs. The strategic geographic shifts towards cost-competitive regions like Asia-Pacific and the emergence of integrated CRO-CDMO models offering comprehensive solutions underscore the dynamic growth of this market.

Pharmaceutical Contract Manufacturing And Research Services Market Report Highlights:

  • Based on service, pharmaceutical contract manufacturing services dominated the market with over 60.0% of the total revenue share in 2024, driven by the need for scale and cost efficiency in producing generics, biosimilars, and vaccines.
  • Contract manufacturers offer essential capacity, flexibility, and regulatory support, facilitating growth in regions like Asia-Pacific.
  • Pharmaceutical contract research services are projected to witness the fastest CAGR of 7.0% over the forecast period.
  • Increasing R&D in complex areas and the demand for CROs' specialized expertise offer cost and time savings in global trials through advanced technologies and navigating regulatory complexities.
  • The Asia Pacific pharmaceutical contract manufacturing and research services market dominated the global market with a revenue share of more than 40.0% in 2024, supported by increased outsourcing in developing economies like Singapore, China, and India, which have expanding manufacturing capabilities and significant CMO investments.
  • In November 2024, Lonza (Switzerland) announced a significant expansion of its bioconjugation capabilities in Visp. This investment includes adding two 1,200L manufacturing suites to meet increasing market demand.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Service
    • 1.2.2. Regional scope
    • 1.2.3. Estimates and forecasts timeline
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
    • 1.4.5. Details of primary research
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Service outlook
    • 2.2.2. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Pharmaceutical Contract Manufacturing And Research Services Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
    • 3.2.2. Market restraint analysis
  • 3.3. Pharmaceutical Contract Manufacturing And Research Services Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Supplier power
      • 3.3.1.2. Buyer power
      • 3.3.1.3. Substitution threat
      • 3.3.1.4. Threat of new entrant
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Technological landscape
      • 3.3.2.3. Economic landscape

Chapter 4. Pharmaceutical Contract Manufacturing And Research Services Market: Service Estimates & Trend Analysis

  • 4.1. Service Segment Dashboard
  • 4.2. Pharmaceutical Contract Manufacturing And Research Services Market: Service Movement Analysis
  • 4.3. Global Pharmaceutical Contract Manufacturing And Research Services Market Size & Trend Analysis, by Service, 2018 to 2030 (USD Million)
  • 4.4. Manufacturing
    • 4.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.2. API/Bulk Drugs
      • 4.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.3. Advanced Drug Delivery Formulations
      • 4.4.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.4. Packaging
      • 4.4.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.5. Finished Dose Formulations
      • 4.4.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
      • 4.4.5.2. Solid
        • 4.4.5.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
      • 4.4.5.3. Liquid
        • 4.4.5.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
      • 4.4.5.4. Semi-solid Formulations
        • 4.4.5.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.5. Research
    • 4.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.5.2. Oncology
      • 4.5.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.5.3. Vaccines
      • 4.5.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.5.4. Inflammation & Immunology
      • 4.5.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.5.5. Cardiology
      • 4.5.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.5.6. Neuroscience
      • 4.5.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.5.7. Others
      • 4.5.7.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 5. Pharmaceutical Contract Manufacturing And Research Services Market: Regional Estimates & Trend Analysis

  • 5.1. Regional Market Dashboard
  • 5.2. Regional Market Share Analysis, 2024 & 2030
  • 5.3. Pharmaceutical contract manufacturing and research services market by Region: Key Takeaways
  • 5.4. North America
    • 5.4.1. U.S.
      • 5.4.1.1. Key country dynamics
      • 5.4.1.2. Regulatory framework/ reimbursement structure
      • 5.4.1.3. Competitive scenario
      • 5.4.1.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.4.2. Canada
      • 5.4.2.1. Key country dynamics
      • 5.4.2.2. Regulatory framework/ reimbursement structure
      • 5.4.2.3. Competitive scenario
      • 5.4.2.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.4.3. Mexico
      • 5.4.3.1. Key country dynamics
      • 5.4.3.2. Regulatory framework/ reimbursement structure
      • 5.4.3.3. Competitive scenario
      • 5.4.3.4. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.5. Europe
    • 5.5.1. UK
      • 5.5.1.1. Key country dynamics
      • 5.5.1.2. Regulatory framework/ reimbursement structure
      • 5.5.1.3. Competitive scenario
      • 5.5.1.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.5.2. Germany
      • 5.5.2.1. Key country dynamics
      • 5.5.2.2. Regulatory framework/ reimbursement structure
      • 5.5.2.3. Competitive scenario
      • 5.5.2.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.5.3. France
      • 5.5.3.1. Key country dynamics
      • 5.5.3.2. Regulatory framework/ reimbursement structure
      • 5.5.3.3. Competitive scenario
      • 5.5.3.4. France market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.5.4. Italy
      • 5.5.4.1. Key country dynamics
      • 5.5.4.2. Regulatory framework/ reimbursement structure
      • 5.5.4.3. Competitive scenario
      • 5.5.4.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.5.5. Spain
      • 5.5.5.1. Key country dynamics
      • 5.5.5.2. Regulatory framework/ reimbursement structure
      • 5.5.5.3. Competitive scenario
      • 5.5.5.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.5.6. Denmark
      • 5.5.6.1. Key country dynamics
      • 5.5.6.2. Regulatory framework/ reimbursement structure
      • 5.5.6.3. Competitive scenario
      • 5.5.6.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.5.7. Sweden
      • 5.5.7.1. Key country dynamics
      • 5.5.7.2. Regulatory framework/ reimbursement structure
      • 5.5.7.3. Competitive scenario
      • 5.5.7.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.5.8. Norway
      • 5.5.8.1. Key country dynamics
      • 5.5.8.2. Regulatory framework/ reimbursement structure
      • 5.5.8.3. Competitive scenario
      • 5.5.8.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.6. Asia Pacific
    • 5.6.1. China
      • 5.6.1.1. Key country dynamics
      • 5.6.1.2. Regulatory framework/ reimbursement structure
      • 5.6.1.3. Competitive scenario
      • 5.6.1.4. China market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.6.2. Japan
      • 5.6.2.1. Key country dynamics
      • 5.6.2.2. Regulatory framework/ reimbursement structure
      • 5.6.2.3. Competitive scenario
      • 5.6.2.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.6.3. India
      • 5.6.3.1. Key country dynamics
      • 5.6.3.2. Regulatory framework/ reimbursement structure
      • 5.6.3.3. Competitive scenario
      • 5.6.3.4. India market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.6.4. Australia
      • 5.6.4.1. Key country dynamics
      • 5.6.4.2. Regulatory framework/ reimbursement structure
      • 5.6.4.3. Competitive scenario
      • 5.6.4.4. Australia market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.6.5. South Korea
      • 5.6.5.1. Key country dynamics
      • 5.6.5.2. Regulatory framework/ reimbursement structure
      • 5.6.5.3. Competitive scenario
      • 5.6.5.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.6.6. Thailand
      • 5.6.6.1. Key country dynamics
      • 5.6.6.2. Regulatory framework/ reimbursement structure
      • 5.6.6.3. Competitive scenario
      • 5.6.6.4. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.7. Latin America
    • 5.7.1. Brazil
      • 5.7.1.1. Key country dynamics
      • 5.7.1.2. Regulatory framework/ reimbursement structure
      • 5.7.1.3. Competitive scenario
      • 5.7.1.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.7.2. Argentina
      • 5.7.2.1. Key country dynamics
      • 5.7.2.2. Regulatory framework/ reimbursement structure
      • 5.7.2.3. Competitive scenario
      • 5.7.2.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.8. MEA
    • 5.8.1. South Africa
      • 5.8.1.1. Key country dynamics
      • 5.8.1.2. Regulatory framework/ reimbursement structure
      • 5.8.1.3. Competitive scenario
      • 5.8.1.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.8.2. Saudi Arabia
      • 5.8.2.1. Key country dynamics
      • 5.8.2.2. Regulatory framework/ reimbursement structure
      • 5.8.2.3. Competitive scenario
      • 5.8.2.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.8.3. UAE
      • 5.8.3.1. Key country dynamics
      • 5.8.3.2. Regulatory framework/ reimbursement structure
      • 5.8.3.3. Competitive scenario
      • 5.8.3.4. UAE market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.8.4. Kuwait
      • 5.8.4.1. Key country dynamics
      • 5.8.4.2. Regulatory framework/ reimbursement structure
      • 5.8.4.3. Competitive scenario
      • 5.8.4.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 6. Competitive Landscape

  • 6.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 6.2. Company/Competition Categorization
  • 6.3. Vendor Landscape
    • 6.3.1. Key company heat map analysis, 2024
  • 6.4. Company Profiles
    • 6.4.1. Catalent, Inc (Novo Holdings A/S)
      • 6.4.1.1. Company overview
      • 6.4.1.2. Financial performance
      • 6.4.1.3. Product benchmarking
      • 6.4.1.4. Strategic initiatives
    • 6.4.2. PPD (Thermo Fisher Scientific Inc.)
      • 6.4.2.1. Company overview
      • 6.4.2.2. Financial performance
      • 6.4.2.3. Product benchmarking
      • 6.4.2.4. Strategic initiatives
    • 6.4.3. AbbVie Inc.
      • 6.4.3.1. Company overview
      • 6.4.3.2. Financial performance
      • 6.4.3.3. Product benchmarking
      • 6.4.3.4. Strategic initiatives
    • 6.4.4. Advent International, L.P.
      • 6.4.4.1. Company overview
      • 6.4.4.2. Financial performance
      • 6.4.4.3. Product benchmarking
      • 6.4.4.4. Strategic initiatives
    • 6.4.5. Grifols
      • 6.4.5.1. Company overview
      • 6.4.5.2. Financial performance
      • 6.4.5.3. Product benchmarking
      • 6.4.5.4. Strategic initiatives
    • 6.4.6. Dalton Pharma Services
      • 6.4.6.1. Company overview
      • 6.4.6.2. Financial performance
      • 6.4.6.3. Product benchmarking
      • 6.4.6.4. Strategic initiatives
    • 6.4.7. Boehringer Ingelheim International GmbH
      • 6.4.7.1. Company overview
      • 6.4.7.2. Financial performance
      • 6.4.7.3. Product benchmarking
      • 6.4.7.4. Strategic initiatives
    • 6.4.8. Lonza
      • 6.4.8.1. Company overview
      • 6.4.8.2. Financial performance
      • 6.4.8.3. Product benchmarking
      • 6.4.8.4. Strategic initiatives

List of Tables

  • Table 1 List of abbreviations
  • Table 2 Global pharmaceutical contract manufacturing and research services market, by region, 2018 - 2030 (USD Million)
  • Table 3 Global pharmaceutical contract manufacturing and research services market, by service, 2018 - 2030 (USD Million)
  • Table 4 North America pharmaceutical contract manufacturing and research services market, by country, 2018 - 2030 (USD Million)
  • Table 5 North America pharmaceutical contract manufacturing and research services market, by service, 2018 - 2030 (USD Million)
  • Table 6 U.S. pharmaceutical contract manufacturing and research services market, by service, 2018 - 2030 (USD Million)
  • Table 7 Canada pharmaceutical contract manufacturing and research services market, by service, 2018 - 2030 (USD Million)
  • Table 8 Mexico pharmaceutical contract manufacturing and research services market, by service, 2018 - 2030 (USD Million)
  • Table 9 Europe pharmaceutical contract manufacturing and research services market, by country, 2018 - 2030 (USD Million)
  • Table 10 Europe pharmaceutical contract manufacturing and research services market, by service, 2018 - 2030 (USD Million)
  • Table 11 UK pharmaceutical contract manufacturing and research services market, by service, 2018 - 2030 (USD Million)
  • Table 12 Germany pharmaceutical contract manufacturing and research services market, by service, 2018 - 2030 (USD Million)
  • Table 13 France pharmaceutical contract manufacturing and research services market, by service, 2018 - 2030 (USD Million)
  • Table 14 Italy pharmaceutical contract manufacturing and research services market, by service, 2018 - 2030 (USD Million)
  • Table 15 Spain pharmaceutical contract manufacturing and research services market, by service, 2018 - 2030 (USD Million)
  • Table 16 Denmark pharmaceutical contract manufacturing and research services market, by service, 2018 - 2030 (USD Million)
  • Table 17 Sweden pharmaceutical contract manufacturing and research services market, by service, 2018 - 2030 (USD Million)
  • Table 18 Norway pharmaceutical contract manufacturing and research services market, by service, 2018 - 2030 (USD Million)
  • Table 19 Asia Pacific pharmaceutical contract manufacturing and research services market, by country, 2018 - 2030 (USD Million)
  • Table 20 Asia Pacific pharmaceutical contract manufacturing and research services market, by service, 2018 - 2030 (USD Million)
  • Table 21 China pharmaceutical contract manufacturing and research services market, by service, 2018 - 2030 (USD Million)
  • Table 22 Japan pharmaceutical contract manufacturing and research services market, by service, 2018 - 2030 (USD Million)
  • Table 23 India pharmaceutical contract manufacturing and research services market, by service, 2018 - 2030 (USD Million)
  • Table 24 Australia pharmaceutical contract manufacturing and research services market, by service, 2018 - 2030 (USD Million)
  • Table 25 South Korea pharmaceutical contract manufacturing and research services market, by service, 2018 - 2030 (USD Million)
  • Table 26 Thailand pharmaceutical contract manufacturing and research services market, by service, 2018 - 2030 (USD Million)
  • Table 27 Latin America pharmaceutical contract manufacturing and research services market, by country, 2018 - 2030 (USD Million)
  • Table 28 Latin America pharmaceutical contract manufacturing and research services market, by service, 2018 - 2030 (USD Million)
  • Table 29 Brazil pharmaceutical contract manufacturing and research services market, by service, 2018 - 2030 (USD Million)
  • Table 30 Argentina pharmaceutical contract manufacturing and research services market, by service, 2018 - 2030 (USD Million)
  • Table 31 MEA pharmaceutical contract manufacturing and research services market, by region, 2018 - 2030 (USD Million)
  • Table 32 MEA pharmaceutical contract manufacturing and research services market, by service, 2018 - 2030 (USD Million)
  • Table 33 South Africa pharmaceutical contract manufacturing and research services market, by service, 2018 - 2030 (USD Million)
  • Table 34 Saudi Arabia pharmaceutical contract manufacturing and research services market, by service, 2018 - 2030 (USD Million)
  • Table 35 UAE pharmaceutical contract manufacturing and research services market, by service, 2018 - 2030 (USD Million)
  • Table 36 Kuwait pharmaceutical contract manufacturing and research services market, by service, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Primary interviews
  • Fig. 5 Market research approaches
  • Fig. 6 Value-chain-based sizing & forecasting
  • Fig. 7 QFD modeling for market share assessment
  • Fig. 8 Market formulation & validation
  • Fig. 9 Pharmaceutical contract manufacturing and research services market: market outlook
  • Fig. 10 Pharmaceutical contract manufacturing and research services competitive insights
  • Fig. 11 Parent market outlook
  • Fig. 12 Related/ancillary market outlook
  • Fig. 13 Penetration and growth prospect mapping
  • Fig. 14 Industry value chain analysis
  • Fig. 15 Pharmaceutical contract manufacturing and research services market driver impact
  • Fig. 16 Pharmaceutical contract manufacturing and research services market restraint impact
  • Fig. 17 Pharmaceutical contract manufacturing and research services market strategic initiatives analysis
  • Fig. 18 Pharmaceutical contract manufacturing and research services market: Service movement analysis
  • Fig. 19 Pharmaceutical contract manufacturing and research services market: Service outlook and key takeaways
  • Fig. 20 Manufacturing estimates and forecast, 2018 - 2030
  • Fig. 21 API/bulk drugs estimates and forecast, 2018 - 2030
  • Fig. 22 Advanced drug delivery formulations estimates and forecast, 2018 - 2030
  • Fig. 23 Packaging estimates and forecast, 2018 - 2030
  • Fig. 24 Finished dose formulations estimates and forecast, 2018 - 2030
  • Fig. 25 Solid estimates and forecast, 2018 - 2030
  • Fig. 26 Liquid estimates and forecast, 2018 - 2030
  • Fig. 27 Semi-solid formulations estimates and forecast, 2018 - 2030
  • Fig. 28 Research estimates and forecast, 2018 - 2030
  • Fig. 29 Oncology estimates and forecast, 2018 - 2030
  • Fig. 30 Vaccines estimates and forecast, 2018 - 2030
  • Fig. 31 Inflammation & immunology estimates and forecast, 2018 - 2030
  • Fig. 32 Cardiology estimates and forecast, 2018 - 2030
  • Fig. 33 Neuroscience estimates and forecast, 2018 - 2030
  • Fig. 34 Others estimates and forecast, 2018 - 2030
  • Fig. 35 Global pharmaceutical contract manufacturing and research services market: Regional movement analysis
  • Fig. 36 Global pharmaceutical contract manufacturing and research services market: Regional outlook and key takeaways
  • Fig. 37 North America market estimates and forecasts, 2018 - 2030
  • Fig. 38 U.S. market estimates and forecasts, 2018 - 2030
  • Fig. 39 Canada market estimates and forecasts, 2018 - 2030
  • Fig. 40 Mexico market estimates and forecasts, 2018 - 2030
  • Fig. 41 Europe market estimates and forecasts, 2018 - 2030
  • Fig. 42 UK market estimates and forecasts, 2018 - 2030
  • Fig. 43 Germany market estimates and forecasts, 2018 - 2030
  • Fig. 44 France market estimates and forecasts, 2018 - 2030
  • Fig. 45 Italy market estimates and forecasts, 2018 - 2030
  • Fig. 46 Spain market estimates and forecasts, 2018 - 2030
  • Fig. 47 Denmark market estimates and forecasts, 2018 - 2030
  • Fig. 48 Sweden market estimates and forecasts, 2018 - 2030
  • Fig. 49 Norway market estimates and forecasts, 2018 - 2030
  • Fig. 50 Asia Pacific market estimates and forecasts, 2018 - 2030
  • Fig. 51 China market estimates and forecasts, 2018 - 2030
  • Fig. 52 Japan market estimates and forecasts, 2018 - 2030
  • Fig. 53 India market estimates and forecasts, 2018 - 2030
  • Fig. 54 Australia market estimates and forecasts, 2018 - 2030
  • Fig. 55 South Korea market estimates and forecasts, 2018 - 2030
  • Fig. 56 Thailand market estimates and forecasts, 2018 - 2030
  • Fig. 57 Latin America market estimates and forecasts, 2018 - 2030
  • Fig. 58 Brazil market estimates and forecasts, 2018 - 2030
  • Fig. 59 Argentina market estimates and forecasts, 2018 - 2030
  • Fig. 60 Middle East and Africa market estimates and forecasts, 2018 - 2030
  • Fig. 61 South Africa market estimates and forecasts, 2018 - 2030
  • Fig. 62 Saudi Arabia market estimates and forecasts, 2018 - 2030
  • Fig. 63 UAE market estimates and forecasts, 2018 - 2030
  • Fig. 64 Kuwait market estimates and forecasts, 2018 - 2030